影响剂量学计算变异性的因素国际研究第4部分:拟合函数对估算吸收剂量的影响
核医学与分子影像学会剂量学工作组利用2例接受177Lu-DOTATATE治疗患者的匿名数据开展国际挑战,评估不同拟合与积分方法对吸收剂量计算变异性的影响。患者A肾脏因拟合步骤产生的吸收剂量变异性小于1%,患者B肾脏变异性低于10%,病灶拟合变异性在25%以内。拟合与积分所致变异性对健康器官较小,遵循适当函数选择、药代动力学建模和合理性检查等建议可进一步降低。
要点
- 患者A肾脏因拟合步骤产生的吸收剂量变异性小于1%。
- 患者B肾脏拟合变异性低于10%,病灶拟合变异性在25%以内。
- 拟合与积分所致变异性对健康器官较小,遵循建议可进一步降低。
核心结论
- 拟合与积分所致的变异性对健康器官较小,遵循适当函数选择、药代动力学建模和合理性检查等建议可进一步降低该变异性。
研究设计与样本
- 核医学与分子影像学会剂量学工作组发起177Lu剂量学挑战,使用2例接受177Lu-DOTATATE治疗患者的匿名数据集(含系列SPECT/CT、分割器官与病灶、时间积分活度图)在线供参与者计算剂量学并标准化提交结果。
主要发现
- 患者A肾脏因拟合步骤产生的吸收剂量变异性小于1%,患者B肾脏拟合变异性低于10%。
- 病灶拟合变异性高于肾脏,变异性在25%以内。
关键数值与推荐
- 拟合方法被分类,相对吸收剂量变异性采用四分位离散系数和四分位距分析。
临床怎么用
- 遵循适当函数选择、药代动力学建模和合理性检查等建议,可进一步降低拟合与积分所致的变异性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Individualized radiopharmaceutical therapies guided by patient-specific absorbed dose (AD) assessments using nuclear medicine imaging have the potential to improve both efficacy and safety. Understanding sources of variability in AD calculations is critical for standardization. The Society of Nuclear Medicine and Molecular Imaging Dosimetry Task Force launched the 177Lu Dosimetry Challenge to evaluate variability across steps within the dosimetry workflow. This work aimed to assess the variability in ADs due to different fitting and integration methods. Methods: Anonymized datasets from 2 patients treated with 177Lu-DOTATATE, including serial SPECT/CT scans, segmented organs and lesions, and time-integrated activity maps, were made available online. Participants were invited to perform dosimetry calculations and submit their results using standardized submission spreadsheets. Fitting approaches were categorized, and relative AD variability was analyzed using the quartile coefficient of dispersion and interquartile range. Results: The variability in AD due to the fitting step for patient A's kidneys was less than 1%. In contrast, patient B's kidneys showed higher variability, with values below 10%. Lesions exhibited more variability in fitting than did kidneys, with variability within 25%. Conclusion: The contribution of variability caused by fitting and integration is small for healthy organs. By following recommendations such as selection of appropriate functions, pharmacokinetic modeling, and sanity checks, this variability can be further reduced.
引用
- Kurkowska S, Brosch-Lenz J, Dewaraja YK, et al. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 4: Impact of Fitting Functions in Estimated Absorbed Doses. J Nucl Med. 2025. PMID: 39978818. doi:10.2967/jnumed.124.268612
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。